Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1

No abstract is available for this paper.

• Publication year

  2011

• Venue

  EMBO Journal

• Publication date

  2011-11-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/emboj.2011.372PMID 22002539PMCID PMC3243616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• γ-Secretase inhibitors and modulators.

  2013cited by this paper
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• Functional Analysis of the Transmembrane Domains of Presenilin 1

  2010cited by this paper
• Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.

  2010influential reference
• β-Amyloid Precursor Protein Mutants Respond to γ-Secretase Modulators*♦

  2010cited by this paper
• Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site

  2010cited by this paper
• Amyloid beta 42 peptide (Aβ42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization

  2010cited by this paper
• Participation of Transmembrane Domain 1 of Presenilin 1 in the Catalytic Pore Structure of the γ-Secretase

  2010cited by this paper
• The secretases: enzymes with therapeutic potential in Alzheimer disease

  2010cited by this paper
• Alzheimer's failure raises questions about disease-modifying strategies

  2010cited by this paper
• γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment

  2009influential reference
• Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein.

  2009cited by this paper
• Secretase inhibitors and modulators for Alzheimer’s disease treatment

  2009cited by this paper
• Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

  2009cited by this paper
• Inhibition of gamma-secretase activity by helical beta-peptide foldamers.

  2009cited by this paper
• Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β42/40 Ratio

  2009cited by this paper
• The C-Terminal PAL Motif and Transmembrane Domain 9 of Presenilin 1 Are Involved in the Formation of the Catalytic Pore of the γ-Secretase

  2008cited by this paper
• Substrate-targeting γ-secretase modulators

  2008cited by this paper
• Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.

  2008cited by this paper
• Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation*

  2008influential reference
• Phosphoinositides Suppress γ-Secretase in Both the Detergent-soluble and -insoluble States*

  2008cited by this paper
• P2‐338: Substrate‐targeting gamma‐secretase modulators

  2008cited by this paper
• Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate.

  2007cited by this paper
• Aβ42 Overproduction Associated with Structural Changes in the Catalytic Pore of γ-Secretase

  2007cited by this paper
• Divergent synthesis of multifunctional molecular probes to elucidate the enzyme specificity of dipeptidic gamma-secretase inhibitors.

  2007cited by this paper
• Three-dimensional structure of the gamma-secretase complex.

  2006cited by this paper
• Signal peptide peptidase: biochemical properties and modulation by nonsteroidal antiinflammatory drugs.

  2006cited by this paper
• Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines.

  2006cited by this paper
• Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase.

  2006cited by this paper
• Secretion of the Notch-1 Abeta-like peptide during Notch signaling.

  2006cited by this paper
• C-terminal Fragment of Presenilin Is the Molecular Target of a Dipeptidic γ-Secretase-specific Inhibitor DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Butyl Ester)*

  2006cited by this paper
• Equimolar Production of Amyloid β-Protein and Amyloid Precursor Protein Intracellular Domain from β-Carboxyl-terminal Fragment by γ-Secretase*

  2006cited by this paper
• Secretion of the Notch-1 Aβ-like Peptide during Notch Signaling*

  2006cited by this paper
• Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase

  2005influential reference
• Pen-2 Is Incorporated into the γ-Secretase Complex through Binding to Transmembrane Domain 4 of Presenilin 1*

  2005cited by this paper
• Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.

  2005influential reference
• Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation

  2004cited by this paper
• Selective Reconstitution and Recovery of Functional γ-Secretase Complex on Budded Baculovirus Particles*[boxs]

  2004cited by this paper
• The role of presenilin cofactors in the gamma-secretase complex.

  2003cited by this paper
• Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation*

  2003cited by this paper
• The role of presenilin cofactors in the γ-secretase complex

  2003cited by this paper
• Designed helical peptides inhibit an intramembrane protease.

  2003cited by this paper
• Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation.

  2003cited by this paper
• Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.

  2003cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.

  2000cited by this paper
• Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1

  2000cited by this paper
• Total inactivation of γ–secretase activity in presenilin-deficient embryonic stem cells

  2000cited by this paper
• Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.

  2000cited by this paper
• C Terminus of Presenilin Is Required for Overproduction of Amyloidogenic Aβ42 through Stabilization and Endoproteolysis of Presenilin

  1999cited by this paper
• The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid b protein ending at the 42nd (or 43rd) residue

  1997cited by this paper
• The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

  1997cited by this paper
• Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain.

  1996cited by this paper
• Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

  1994cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• An approach to the targeted attachment of peptides and proteins to solid supports.

  1976cited by this paper
• [An approach to the targeted attachment of peptides and proteins to solid supports].

  1976cited by this paper

• Acoplamiento molecular entre fármacos para Alzheimer y la enzima γ-secretasa.

  2025cites this paper
• γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds

  2025cites this paper
• The advent of Alzheimer treatments will change the trajectory of human aging

  2024cites this paper
• How Modulator Binding at the Amyloidβ-γ-Secretase Interface Enhances Substrate Binding and Attenuates Membrane Distortion.

  2023cites this paper
• γ-Secretase in Alzheimer’s disease

  2022cites this paper
• Targeting PSEN1 by lnc-CYP3A43-2/miR-29b-2-5p to Reduce β Amyloid Plaque Formation and Improve Cognition Function

  2022cites this paper
• GPR120 Signaling Controls Amyloid-b Degrading Activity of Matrix Metalloproteinases

  2021cites this paper
• Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides

  2021cites this paper
• GPR120 Signaling Controls Amyloid-β Degrading Activity of Matrix Metalloproteinases

  2021cites this paper
• Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators.

  2021cites this paper
• Understanding familial Alzheimer's disease: The fit‐stay‐trim mechanism of γ‐secretase

  2021cites this paper
• Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.

  2020cites this paper
• Structure-activity relationship of presenilin in γ-secretase-mediated intramembrane cleavage.

  2020cites this paper
• Pathogenic Aβ generation in familial Alzheimer's disease: novel mechanistic insights and therapeutic implications.

  2020cites this paper
• Cryo-temperature effects on membrane protein structure and dynamics.

  2020cites this paper
• Computational prediction and molecular mechanism of γ-secretase modulators.

  2020cites this paper
• γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

  2020cites this paper
• Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease

  2020cites this paper
• Successive cleavage of β-amyloid precursor protein by γ-secretase.

  2020cites this paper
• Conformational Dynamics of Transmembrane Domain 3 of Presenilin 1 Is Associated with the Trimming Activity of γ-Secretase

  2019cites this paper
• Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies

  2019cites this paper
• γ-Secretase and its modulators: Twenty years and beyond.

  2019cites this paper
• Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.

  2018cites this paper
• Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse

  2018cites this paper
• Specific mutations in presenilin 1 cause conformational changes in &ggr;-secretase to modulate amyloid &bgr; trimming

  2018cites this paper
• Retrograde transport of γ‐secretase from endosomes to the trans‐Golgi network regulates Aβ42 production

  2018cites this paper
• Molecular Recipe for γ-Secretase Modulation from Computational Analysis of 60 Active Compounds

  2018cites this paper
• Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice

  2018cites this paper
• Pathogenic PS1 phosphorylation at Ser367

  2017cites this paper
• Phenotypic heterogeneity and preclinical change in familial Alzheimer's disease

  2017cites this paper
• Probing the Structure and Function Relationships of Presenilin by Substituted-Cysteine Accessibility Method.

  2017cites this paper
• Analyzing Amyloid-β Peptide Modulation Profiles and Binding Sites of γ-Secretase Modulators.

  2017cites this paper
• Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production

  2017cites this paper
• γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease

  2017cites this paper
• Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer’s Disease Pathogenesis

  2017cites this paper
• Targeting γ-Secretase for the Treatment of Alzheimer’s Disease

  2017cites this paper
• Generation of Amyloid‐β Peptides by γ‐Secretase

  2017cites this paper
• Activation of γ-Secretase Trimming Activity by Topological Changes of Transmembrane Domain 1 of Presenilin 1

  2017cites this paper
• Alzheimer’s Disease II

  2017cites this paper
• Utilising the MultiBac expression system to reconstruct and purify the gamma secretase enzyme

  2017cites this paper
• Synergistic inhibition of A&bgr; production by combinations of &ggr;‐secretase modulators

  2017cites this paper
• Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.

  2017cites this paper
• Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.

  2016cites this paper
• Therapeutic Targeting of Aβ42

  2016cites this paper
• Beyond Chemoselectivity: Catalytic Site-Selective Aldolization of Diketones and Exploitation for Enantioselective Alzheimer's Drug Candidate Synthesis.

  2016cites this paper
• Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

  2016cites this paper
• Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects

  2016cites this paper
• Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation

  2016cites this paper
• Development of Sulfonamide Photoaffinity Inhibitors for Probing Cellular γ-Secretase.

  2016cites this paper
• Intramembrane proteolysis within lysosomes.

  2016cites this paper
• The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore.

  2016cites this paper
• Conformational Changes in Transmembrane Domain 4 of Presenilin 1 Are Associated with Altered Amyloid-β 42 Production

  2016cites this paper
• Potent benzoazepinone γ-secretase modulators with improved bioavailability.

  2015cites this paper
• Synthetic ceramide analogues increase amyloid-β 42 production by modulating γ-secretase activity.

  2015cites this paper
• Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate γ-Secretase Activities*

  2015cites this paper
• Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond.

  2015cites this paper
• Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator

  2015cites this paper
• Natural Product and Natural Product-Derived Gamma Secretase Modulators from Actaea Racemosa Extracts

  2015cites this paper
• Organofluorine Compounds in Neurological Disorders

  2015cites this paper
• γ-Secretase Modulators and Inhibitors Induce Different Conformational Changes of Presenilin 1 Revealed by FLIM and FRET

  2015cites this paper
• Cooperative Roles of Hydrophilic Loop 1 and the C-Terminus of Presenilin 1 in the Substrate-Gating Mechanism of γ-Secretase

  2015cites this paper
• Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.

  2015cites this paper
• Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans

  2015cites this paper
• Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment

  2015cites this paper
• Structural Interactions between Inhibitor and Substrate Docking Sites Give Insight into Mechanisms of Human PS1 Complexes

  2014cites this paper
• A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases.

  2014influential citation
• γ-Secretase modulators: current status and future directions.

  2014cites this paper
• Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator

  2014cites this paper
• Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators.

  2014cites this paper
• Binding of longer Aβ to transmembrane domain 1 of presenilin 1 impacts on Aβ42 generation

  2014cites this paper
• Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780

  2014cites this paper
• Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and γ-Secretase Processivity

  2014cites this paper
• Complex Relationships between Substrate Sequence and Sensitivity to Alterations in γ-Secretase Processivity Induced by γ-Secretase Modulators

  2014cites this paper
• Molecular mechanism of intramembrane proteolysis by γ-secretase.

  2014cites this paper
• Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates

  2014cites this paper
• Substrate determinants in the C99 juxtamembrane domains differentially affect γ–secretase cleavage specificity and modulator pharmacology

  2013cites this paper
• Suspected limited efficacy of γ-secretase modulators.

  2013cites this paper
• Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.

  2013cites this paper
• Inhibition of γ-secretase activity by a monoclonal antibody against the extracellular hydrophilic loop of presenilin 1.

  2013cites this paper
• Development and mechanism of γ-secretase modulators for Alzheimer's disease.

  2013cites this paper
• Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Alzheimer’s disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production

  2013cites this paper
• Experimental detection of proteolytic activity in a signal peptide peptidase of Arabidopsis thaliana

  2013cites this paper
• γ-Secretase inhibitors and modulators.

  2013cites this paper
• Aftins Increase Amyloid-β42, Lower Amyloid-β38, and Do Not Alter Amyloid-β40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease?

  2013cites this paper
• Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models

  2013cites this paper
• γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin*

  2013cites this paper
• Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions*

  2013cites this paper
• Steroids as γ‐secretase modulators

  2013cites this paper
• Structural Biology of Presenilins and Signal Peptide Peptidases*

  2013cites this paper
• Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein.

  2013cites this paper
• Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

  2013cites this paper
• In-silico screening of potential inhibitors of gamma-secretase, a key enzyme of Alzheimer’s disease

  2013cites this paper
• An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.

  2013cites this paper
• γ-Secretase Associated with Lipid Rafts

  2013cites this paper
• Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells

  2012cites this paper
• Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

  2012cites this paper
• Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

  2012cites this paper
• Secretase Inhibitors and Modulators as a Disease-Modifying Approach Against Alzheimer's Disease

  2012cites this paper